Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease

NCT04569825 is registered in ClinicalTrials.gov with University Of Anbar as lead sponsor.

NCT NCT04569825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04569825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease
Lead sponsor
University Of Anbar
Phase
Phase 1
Overall status
Unknown status
Start date
August 1, 2020
Completion date
October 15, 2020
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical trial